Natus Medical Announces 2017 Annual and First Quarter

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
68
Natus Medical Announces 2017 Annual and First Quarter Financial Guidance
  • Updates Fourth Quarter 2016 Revenue
  • Announces Fourth Quarter 2016 Financial Results Conference Call Date

PLEASANTON, Calif., Jan. 09, 2017 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY ) today announced its financial guidance for the first quarter and full year 2017.

For the full year 2017, the Company expects to report revenue of $505.0 to $510.0 million and non-GAAP earnings per share of $1.80 to $1.85. For the first quarter of 2017, the Company expects to report revenue of $122.0 to $124.0 million and non-GAAP earnings per share of $0.32 to $0.34.

The Company expects to report revenue of approximately $107.5 to $108.0 million for the fourth quarter of 2016, compared to prior guidance of $107.0 to $109.0 million and full year 2016 revenue of $381.5 to $382.0 million compared to prior guidance of $381.2 to $383.2 million.

During the fourth quarter of 2016, the Company contracted 23 new Peloton Hearing Screening Hospitals.

The Company also announced that it has completed the previously announced acquisition of Otometrics the business from GN Store Nord.

"The combination of Natus and Otometrics creates a global leader in hearing aid fitting, hearing assessment, hearing screening and balance assessment," said Jim Hawkins, President and Chief Executive Officer of Natus. "The Otometrics brand will complement our current portfolio and will further increase our combined growth potential. In addition, we look forward to expanding Otometrics' margins as we complete the integration of the two companies."

The Company will release its 2016 fourth quarter financial results before the market opens on Wednesday, February 1, 2017.

The Company’s non-GAAP earnings per share guidance excludes charges for amortization expense associated with intangible assets from prior acquisitions, which the Company expects to be approximately $9.8 million and $3.1 million for the full year and first quarter 2017, respectively, and which the Company expects will reduce GAAP earnings per share by approximately $0.25 and $0.07 for the respective periods.  Non-GAAP earnings per share also exclude the direct and transition costs of the Otometrics acquisition, which are estimated to be approximately $3 million to $4 million for the full year 2017 as well as the Otometrics related amortization of acquired intangible assets, which cannot be estimated at this time.

Use of Non-GAAP Financial Guidance

This release contains financial guidance that excludes amortization of acquisition related intangible assets, and restructuring and acquisition-related charges from completed and announced acquisitions. The Company’s non-GAAP earnings per share guidance excludes charges for amortization expense of intangible assets associated with prior acquisitions. The Company believes that the presentation of financial guidance excluding these charges provides meaningful information to both management and investors that is indicative of the Company's core operating results.

About Natus Medical

Natus is a leading provider of healthcare products and services used in the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders.

Forward Looking Statements

This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, particularly statements regarding the expectations, beliefs, plans, intentions and strategies of Natus. These forward-looking statements include statements regarding the anticipated revenue of the fourth quarter of 2016 and the revenue and non-GAAP earnings per share for the first quarter and full year 2017 and the impact of amortization expense associated with acquisition-related intangible assets. These statements relate to current estimates and assumptions of our management as of the date of this press release and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance, or achievements to differ materially from those expressed or implied by the forward-looking statements. Forward-looking statements are only predictions and the actual events or results may differ materially. Natus cannot provide any assurance that its future results or the results implied by the forward-looking statements will meet expectations. Our future results could differ materially due to a number of factors, including the effects of competition, the successful integration of the Otometrics acquisition and achieving our profitability goals for Otometrics, the demand for our products and services, the impact of adverse global economic conditions, including foreign exchange rate changes, on our target markets, our ability to expand our sales in international markets, our ability to maintain current sales levels in a mature domestic market, our ability to control costs, risks associated with bringing new products to market and integrating acquired businesses, shipments and revenue associated with our Medix’ subsidiary’s contract with the Venezuela Ministry of Health and our ability to fulfill product orders on a timely basis. Natus disclaims any obligation to update information contained in any forward looking statement.

More information about potential risk factors that could affect the business and financial results of Natus is included in Natus' annual report on Form 10-K for the year ended December 31, 2015, and its subsequent quarterly reports on Form 10-Q, and in other reports filed from time to time by Natus with the U.S. Securities and Exchange Commission.

Additional information about Natus Medical can be found at www.natus.com .

COMPANY CONTACT: Natus Medical Incorporated Jonathan A. Kennedy Executive Vice President and Chief Financial Officer (925) 223-6700 InvestorRelations@Natus.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

iHeartMedia Faces 65% Drop: Fraud Investigation Launched

Updated Category News Views 150

Trouble Tunes for iHeartMedia Investors Alright folks, here's the skinny on iHeartMedia, Inc. These days, it's like everyone's out for a piece of iHeart, and not in the way you'd wanna see—unless you're SBS Law, those shareholder rights hotshots diving into another pond of legal ripples. Seems a heap of head-scratching's going down on their version of transparency with...

Continue Reading
Grupo Supervielle's Q3 2026: Back to Growth Path

Updated Category News Views 49

Mounting Momentum in Loans and Asset Quality Grupo Supervielle, the Argentine financial player, has been tinkering with its gears to navigate the bumpy roads of 2026. In the third quarter, the company reports a gentle uptick in net loans—up 1.3% sequentially. This was particularly felt in September, with loans increasing 3.7%. Holding Their Own Against the Industry...

Continue Reading
PEGATRON Unveils AI and HPC Advances at SC26

Updated Category News Views 106

Revamping AI with High-Density Computing You know, back in the day, AI was just about training models and running basic inference. But now, it's all about these crazy agentic AI tasks—autonomous agents doing things I couldn't have imagined. PEGATRON's Evolution in Infrastructure PEGATRON's latest move at SC26 is a real leap forward in this ongoing AI saga. They're...

Continue Reading
Lennar Faces Securities Fraud Lawsuit: Investor Insights

Updated Category News Views 208

Investors in Lennar: Navigating the Legal Storm Hold onto your hats, folks. Lennar Corporation (NYSE: LEN) is up against it with a brand-spanking-new securities fraud lawsuit helmed by Schall, Brown & Schwartz LLP (SBS). This isn't just a couple of investors grumbling over cocktails; it’s a full-blown class action that’s waving the legal banner under the Securities...

Continue Reading
Texxon Faces Revenue Slide Amid Strategic Shifts

Updated Category News Views 155

Texxon's Strategic Transitions and Financial Headaches Texxon Holding Limited (NASDAQ:NPT) just laid their cards on the table, unveiling a mixed bag in their fiscal year 2026 results. As the world's chemical and plastics scene faces winds of change, Texxon buckled down and tried to steer the ship clear from the rocks. It's a balancing act juggling market headwinds, a new...

Continue Reading
NEDHSA Amplifies Tobacco-Free Push with 2026 Smokeout

Updated Category News Views 87

2026 Great American Smokeout: A Fresh Push Against Tobacco NEDHSA is sticking to its guns with a tobacco-free campaign that’s got deep roots. The 2026 Great American Smokeout, on November 19, not only highlights past efforts but looks to stir more folks into healthier habits. Beyond the campaign glitz, it’s about dragging a century-long bad habit further into the...

Continue Reading
Ross Pools Joins Forces with Florida Panthers in 2026

Updated Category News Views 327

An Unlikely Team-Up: Pools and Hockey Well, here's one for the books: a South Florida pool company hitching its wagon to an NHL team. Ross Pools, the folks who’ve been carving out backyard oases in the sizzling Florida sun for over two decades, are now officially aligned with the Florida Panthers. Yeah, the same Panthers that snatched the Stanley Cup not once but twice...

Continue Reading
BWIN Acquisition Under Scrutiny: Shareholders Alerted

Updated Category News Views 118

BWIN Shareholders in the Hot Seat Over Acquisition Ever feel like you're the last one to know when the music stops in this investing dance? Well, if you're holding shares of The Baldwin Insurance Group, Inc. (NASDAQ:BWIN), it's time to put down your coffee and tune in. Levi & Korsinsky, LLP threw a wrench in the works, launching an investigation to see if this Sequence...

Continue Reading
Lecanemab Shines in 5-Year Alzheimer's Study at CTAD

Updated Category News Views 172

Latest Lecanemab Results Turn Heads at CTAD 2026 The whispers buzzing out of the CTAD 2026 conference are about something promising for those in the trenches of Alzheimer's research: lecanemab. Yep, it's a name that's been bandied about before, and this time it's the long-term data doing the talking. The five-year results from Eisai and Biogen's lecanemab study are...

Continue Reading
Vertiv's 800 VDC Push Gives AI Builders More Choices

Updated Category News Views 0

Electricity is becoming the awkward roommate inside every serious AI buildout, and Vertiv is trying to move it out of the rack before it eats the whole house. The company has expanded its 800 VDC offering beyond the PowerDirect 5000 rack product introduced in May 2026, laying out systems for the rack, the AI compute pod, and the full data hall. For investors following...

Continue Reading

Top 5 Most Recently Viewed Articles

CNB Community Bancorp Raises Quarterly Dividend to $0.30

Updated Category News Views 103

CNB Community Bancorp Declares Increased Cash Dividend CNB Community Bancorp, Inc. has recently made an exciting announcement regarding its financial strategy. The Board of Directors has officially declared a quarterly cash dividend of $0.30 per share for the company’s common stock. This new dividend reflects an increase of $0.01 per share compared to the previous...

Continue Reading
Exciting Primark Store Opening at Wolfchase Galleria

Updated Category News Views 410

Exciting Primark Store Opening at Wolfchase Galleria Primark, a global favorite in fashion retail, is set to make a splash in the U.S. by opening its first Tennessee store. Located at Wolfchase Galleria, this grand opening signifies a pivotal moment for the brand, as it marks their 31st U.S. location, proudly spreading across various states. With the new store covering...

Continue Reading
Continuous Gold Processing at North Bay Resources' Mill

Updated Category News Views 145

Exciting Developments at North Bay Resources North Bay Resources, Inc. (the “Company” or “North Bay”) (OTC: NBRI) is thrilled to announce the successful continuous operations of its Bishop Gold Mill. Following significant upgrades made recently, the mill has been running successfully for up to nine hours a day. This achievement has led to the processing of...

Continue Reading
Insider Stock Purchase Highlights Marriott Vacations Growth Potential

Updated Category News Views 130

Insight into Recent Stock Transactions A significant insider purchase was reported by Lizanne Galbreath, a Board Member at Marriott Vacations (NYSE: VAC), showcasing her confidence in the company’s future. This transaction involved the acquisition of 5,500 shares, valued at approximately $255,805, as submitted in a Form 4 filing to the SEC. Such transactions often...

Continue Reading
Market Reaction to Potential Fed Chair Nomination Shakes Up Trends

Updated Category News Views 161

Market Reaction to Potential Fed Chair Nomination Recent market trends show significant fluctuations as rumors circulate about President Trump’s forthcoming announcement regarding a new chairman for the Federal Reserve. The spotlight is on former Fed Governor Kevin Warsh, expected to be nominated later today, which sends ripples through the gold and dollar markets....

Continue Reading